Q4 2024 · 13F-HR
NVP Associates, LLCholdings as filed
Filed 2025-02-10 · accession 0001104659-25-010945
$186.9M
Reported value
7
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 23834J201 | DAVE | DAVE INC | $50.6M | 27.1% | 582,675 | Common | SOLE |
| 87427V103 | TALK | TALKSPACE INC | $45.4M | 24.3% | 14,702,972 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $39.4M | 21.1% | 2,136,335 | Common | SOLE |
| 902685106 | 7WH | UDEMY INC | $25.6M | 13.7% | 3,114,732 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $15.1M | 8.05% | 1,838,482 | Common | SOLE |
| 683712103 | OPEN | OPENDOOR TECHNOLOGIES INC | $6.7M | 3.59% | 4,189,562 | Common | SOLE |
| 39957D201 | GROV | GROVE COLLABORATIVE HOLD INC | $4.1M | 2.19% | 2,943,522 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.